Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Loading
Home›
Research›
Investment Firms›
GE Ventures
AddedFeb 13, 2024
UpdatedJun 28, 2026
GE Ventures

GE Ventures

Operating

GE Ventures, a venture capital subsidiary of General Electric, invests in healthcare, energy, software, and advanced manufacturing startups.

Location
Menlo Park, CA, US
Founded
2013
Firm
Compare
Portfolio
Employees

Investments

Catalant Technologies
Catalant Technologies

Total Raised

$145.6M

Rounds

8

Series E$35MJanuary 2020
Series D$41MJune 2017
Balena
Balena

Total Raised

$31.4M

Rounds

5

Series B$14.4MJuly 2019
Corporate Round$5MJune 2018
Acutus Medical
Acutus Medical
Acquired

Total Raised

$343.2M

Rounds

10

Series D$100MJune 2019
Xometry
Xometry
Public

Total Raised

$197.2M

Rounds

9

Series D$50MMay 2019
Series C$25MJuly 2018
Series B$15MJune 2017
Xage Security
Xage Security

Total Raised

$81.2M

Rounds

3

Series A$21MDecember 2018
Aras
Aras

Total Raised

$138.2M

Rounds

11

Series D$70MNovember 2018
Series Unknown$40MSeptember 2017
Sarcos Technology & Robotics
Sarcos Technology & Robotics
Acquired

Total Raised

$316.1M

Rounds

7

Series B$30MSeptember 2018
Evidation Health
Evidation Health

Total Raised

$259M

Rounds

10

Series C$30MAugust 2018
Verana Health
Verana Health

Total Raised

$288.8M

Rounds

5

Series C$30MJuly 2018
Iora Health
Iora Health
Acquired

Total Raised

$349.3M

Rounds

7

Series E$100MMay 2018
Vineti
Vineti

Total Raised

$115.3M

Rounds

4

Series B$33.5MApril 2018
Series A$13.8MJune 2017
Element Analytics
Element Analytics

Total Raised

$40M

Rounds

4

Series A$15MJanuary 2018
Genome Medical
Genome Medical

Total Raised

$120.4M

Rounds

6

Series A$11MJanuary 2018
Carbon
Carbon

Total Raised

$683.4M

Rounds

9

Series D$200MDecember 2017
Apervita
Apervita

Total Raised

$59.5M

Rounds

5

Series Unknown$16.5MNovember 2017
Arterys
Arterys
Acquired

Total Raised

$71.7M

Rounds

9

Series B$30MNovember 2017
Syapse
Syapse
Public

Total Raised

$222.6M

Rounds

9

Series D$30MNovember 2017
Desktop Metal
Desktop Metal
Public

Total Raised

$816.8M

Rounds

13

Series D$115MJuly 2017
Neuronetics
Neuronetics
Public

Total Raised

$373.4M

Rounds

13

Series G$15MJune 2017